Updates

No tissue clearing experience? No problem. Translucence Biosystems is excited to announce the release of our new kit and reagent products that enable researchers to achieve expert-level tissue clearing and staining in their own labs.

At the recent Society for Neuroscience Meeting, we presented our tissue clearing techniques for AI-powered brain-wide measurement of amyloid plaques and plaque-associated microglia (PAMs), our software and reagents for measuring neuronal activity, as well as debuted our Clearly Delicious™️ Gummy Brains.

Translucence Biosystems recently participated in the 9th Annual BRAIN Initiative Meeting: Open Science, New Tools! The conference, held on June 12-13, 2023, aimed to foster a dynamic and collaborative research community through interactions among like-minded scientists who study the brain.

Co-Founder and CEO, Damian Wheeler, presented a poster titled "Brain-Wide Cellular-Resolution Quantification of Microglia and Amyloid" at the Neurodegeneration: New Biology Guiding the Next Generation of Therapeutic Development conference hosted by the by Keystone Symposia on Molecular & Cellular Biology.

At the BIO-SEE 2023 Webinar Series, Damian Wheeler Ph.D., CEO of Translucence Biosystems, presented the company's innovative approach to brain-wide single-cell imaging in a talk entitled "Brain-wide single-cell resolution imaging and machine learning-enabled quantification".

Our team has been working with Lundbeck to monitor therapeutic antibody biodistribution in the brain using tissue clearing and light sheet imaging. Our CEO, Damian Wheeler, Ph.D. presented our findings in our poster titled the "Brain-Wide Cellular-Resolution Measurement of Antibody Therapeutics."